<?xml version="1.0" encoding="UTF-8"?>
<p id="Par49">According to the experiences in diagnosis and treatment of community-acquired pneumonia in children, children with a history of contact with severe 2019-nCoV infected cases, or with underlying conditions (such as congenital heart disease, bronchial pulmonary hypoplasia, respiratory tract anomaly, with abnormal hemoglobin level, severe malnutrition), or with immune deficiency or immunocompromised status (under long-term use of immunosuppressants) who meet any one of the following criteria may become severe cases:
 <list list-type="order">
  <list-item>
   <p id="Par50">Dyspnea: respiratory rate &gt; 50 times/min for 2–12 months old; &gt; 40 times/min for 1–5 years old; &gt; 30 times/min in patients over 5 years old (after ruling out the effects of fever and crying);</p>
  </list-item>
  <list-item>
   <p id="Par51">Persistent high fever for 3–5 days;</p>
  </list-item>
  <list-item>
   <p id="Par52">Poor mental response, lethargy, disturbance of consciousness, and other changes of consciousness;</p>
  </list-item>
  <list-item>
   <p id="Par53">Abnormally increased enzymatic indexes, such as myocardial enzymes, liver enzymes, lactate dehydrogenase;</p>
  </list-item>
  <list-item>
   <p id="Par54">Unexplainable metabolic acidosis;</p>
  </list-item>
  <list-item>
   <p id="Par55">Chest imaging findings indicating bilateral or multi-lobe infiltration, pleural effusion, or rapid progression of conditions during a very short period;</p>
  </list-item>
  <list-item>
   <p id="Par56">Infants younger than 3 months;</p>
  </list-item>
  <list-item>
   <p id="Par57">Extrapulmonary complications;</p>
  </list-item>
  <list-item>
   <p id="Par58">Coinfection with other viruses and/or bacteria.</p>
  </list-item>
 </list>
</p>
